Geode Capital Management LLC boosted its position in shares of Sotera Health (NASDAQ:SHC - Free Report) by 19.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,755,391 shares of the company's stock after purchasing an additional 447,186 shares during the period. Geode Capital Management LLC owned 0.97% of Sotera Health worth $46,026,000 at the end of the most recent reporting period.
Several other large investors also recently added to or reduced their stakes in the company. Darsana Capital Partners LP increased its holdings in shares of Sotera Health by 716.9% in the 3rd quarter. Darsana Capital Partners LP now owns 20,010,000 shares of the company's stock valued at $334,167,000 after purchasing an additional 17,560,636 shares during the period. Sessa Capital IM L.P. increased its stake in Sotera Health by 46.5% in the 3rd quarter. Sessa Capital IM L.P. now owns 6,300,597 shares of the company's stock valued at $105,220,000 after buying an additional 2,000,000 shares during the period. State Street Corp lifted its position in Sotera Health by 18.5% in the 3rd quarter. State Street Corp now owns 4,126,806 shares of the company's stock worth $68,918,000 after buying an additional 644,236 shares in the last quarter. AQR Capital Management LLC boosted its stake in shares of Sotera Health by 3,198.2% during the 2nd quarter. AQR Capital Management LLC now owns 511,580 shares of the company's stock valued at $6,072,000 after buying an additional 496,069 shares during the period. Finally, Barclays PLC boosted its stake in shares of Sotera Health by 169.8% during the 3rd quarter. Barclays PLC now owns 473,597 shares of the company's stock valued at $7,909,000 after buying an additional 298,085 shares during the period. 91.03% of the stock is owned by institutional investors and hedge funds.
Shares of NASDAQ SHC opened at $13.33 on Tuesday. The business's 50-day simple moving average is $14.39 and its 200-day simple moving average is $14.25. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. Sotera Health has a 52 week low of $10.71 and a 52 week high of $17.44. The firm has a market cap of $3.78 billion, a price-to-earnings ratio of 53.32 and a beta of 1.96.
Sotera Health (NASDAQ:SHC - Get Free Report) last released its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 EPS for the quarter, missing analysts' consensus estimates of $0.18 by ($0.01). The firm had revenue of $285.47 million during the quarter, compared to the consensus estimate of $278.64 million. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The company's revenue for the quarter was up 8.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.18 EPS. As a group, equities research analysts expect that Sotera Health will post 0.61 earnings per share for the current fiscal year.
A number of equities analysts have recently weighed in on the stock. Citigroup upped their price target on shares of Sotera Health from $18.00 to $20.00 and gave the stock a "buy" rating in a research note on Wednesday, November 6th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $17.00 target price on shares of Sotera Health in a research report on Thursday, November 21st. Finally, The Goldman Sachs Group started coverage on Sotera Health in a report on Friday, December 6th. They set a "neutral" rating and a $14.00 price target for the company. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $16.08.
Get Our Latest Stock Analysis on SHC
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Sotera Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sotera Health wasn't on the list.
While Sotera Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.